Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.

Infect Dis Ther · 2021 · PMC8272840 · PMID 34247325

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep = 0.12not close (p > 0.1)

(ii) Concerning the non-severe COVID-19 group, the pooled OR was 1.46 the for control arm but did not reach statistical significance (95% CI 0.91–2.34; p = 0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.